Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 3
2008 2
2009 1
2010 2
2011 1
2012 4
2013 3
2014 2
2015 2
2016 3
2017 4
2018 1
2019 4
2020 5
2021 4
2022 4
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

44 results

Results by year

Filters applied: . Clear all
Page 1
Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors.
Strosberg J, El-Haddad G, Wolin E, Hendifar A, Yao J, Chasen B, Mittra E, Kunz PL, Kulke MH, Jacene H, Bushnell D, O'Dorisio TM, Baum RP, Kulkarni HR, Caplin M, Lebtahi R, Hobday T, Delpassand E, Van Cutsem E, Benson A, Srirajaskanthan R, Pavel M, Mora J, Berlin J, Grande E, Reed N, Seregni E, Öberg K, Lopera Sierra M, Santoro P, Thevenet T, Erion JL, Ruszniewski P, Kwekkeboom D, Krenning E; NETTER-1 Trial Investigators. Strosberg J, et al. N Engl J Med. 2017 Jan 12;376(2):125-135. doi: 10.1056/NEJMoa1607427. N Engl J Med. 2017. PMID: 28076709 Free PMC article. Clinical Trial.
Novel PET tracers: added value for endocrine disorders.
Bergeret S, Charbit J, Ansquer C, Bera G, Chanson P, Lussey-Lepoutre C. Bergeret S, et al. Among authors: ansquer c. Endocrine. 2019 Apr;64(1):14-30. doi: 10.1007/s12020-019-01895-z. Epub 2019 Mar 14. Endocrine. 2019. PMID: 30875057 Review.
Response to De Koster and al. Thuillier P, Benisvy D, Ansquer C, Corvilain B, Mirallie E, Taieb D, et al.: What is the role of functional imaging and isotopic treatment? Ann Endocrinol (Paris) 2022. https://doi.org/10.1016/j.ando.2022.10.008.
Thuillier P, Ansquer C, Borson-Chazot F, Lussey-Lepoutre C. Thuillier P, et al. Among authors: ansquer c. Ann Endocrinol (Paris). 2023 Apr;84(2):327-328. doi: 10.1016/j.ando.2023.01.002. Epub 2023 Jan 17. Ann Endocrinol (Paris). 2023. PMID: 36669736 No abstract available.
Exploring Tumor Heterogeneity Using PET Imaging: The Big Picture.
Bailly C, Bodet-Milin C, Bourgeois M, Gouard S, Ansquer C, Barbaud M, Sébille JC, Chérel M, Kraeber-Bodéré F, Carlier T. Bailly C, et al. Among authors: ansquer c. Cancers (Basel). 2019 Aug 31;11(9):1282. doi: 10.3390/cancers11091282. Cancers (Basel). 2019. PMID: 31480470 Free PMC article. Review.
Prospective Multicentric Assessment of 68Ga-DOTANOC PET/CT in Grade 1-2 GEP-NET.
Lugat A, Frampas É, Touchefeu Y, Mirallié É, Bras ML, Senellart H, Rauscher A, Fleury V, Campion L, Rohmer V, Couturier OF, Lebtahi R, Rouzet F, Ruszniewski P, Kraeber-Bodéré F, Bourgeois M, Ansquer C. Lugat A, et al. Among authors: ansquer c. Cancers (Basel). 2023 Jan 14;15(2):513. doi: 10.3390/cancers15020513. Cancers (Basel). 2023. PMID: 36672462 Free PMC article.
Value of Somatostatin Receptor PET/CT in Patients With MEN1 at Various Stages of Their Disease.
Mennetrey C, Le Bras M, Bando-Delaunay A, Al-Mansour L, Haissaguerre M, Batisse-Lignier M, Ouvrard E, Ansquer C, Walter T, de Mestier L, Kelly A, Tlili G, Giraud S, North MO, Odou MF, Goichot B, Cuny T, Loundou A, Romanet P, Imperiale A, Taïeb D. Mennetrey C, et al. Among authors: ansquer c. J Clin Endocrinol Metab. 2022 Apr 19;107(5):e2056-e2064. doi: 10.1210/clinem/dgab891. J Clin Endocrinol Metab. 2022. PMID: 34940846
44 results